Carboplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Carboplatin Injection (injection) from Avyxa Pharma, LLC with status Current. The shortage was first posted on 04/28/2023.
Shortage Details
- Status
- Current
- Company
- Avyxa Pharma, LLC
- Package NDC
- 83831-142-50
- Dosage Form
- Injection
- Presentation
- Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)
- Initial Posting
- 04/28/2023
- Revised Date